No abstract available
Keywords:
Tirzepatide; incretins; legacy effect; pharmacotherapy; type 2 diabetes.
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Gastric Inhibitory Polypeptide
-
Glucagon-Like Peptide-1 Receptor
-
Humans
-
Hypoglycemic Agents / adverse effects
Substances
-
tirzepatide
-
Gastric Inhibitory Polypeptide
-
Hypoglycemic Agents
-
Glucagon-Like Peptide-1 Receptor